Researchers at the Institute of Automation of the Chinese Academy of Sciences have developed a compact, battery-powered brain ...

Neurons are the cells in the brain responsible for sending messages to the rest of the body, and scientists have long thought ...

CEO of Cognito Therapeutics. "The findings build on our previous research, showing that preserving brain connectivity and structure through non-invasive neuromodulation could significantly impact ...

"Improvement" of a technology can always go in various directions. "Brain chips" may offer a greatly improved quality of life ...

MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical ... VENT-02 is a novel, oral, brain-penetrant inhibitor of NLRP3, a key driver of inflammation and component ...

Your brain isn’t stagnant; throughout your lifetime, many changes occur as a result of genetic, hormonal, and environmental factors that accompany emotional, intellectual, and physical ...

BofA analyst Alec Stranahan lowered the firm’s price target on BioXcel Therapeutics (BTAI) to $1 from $4 and keeps an Underperform rating on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NEW HAVEN, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...

AI-powered stock picks with a proven track record to beat the S&P 500.

Mapping the density, molecular features and energy-transformation capacity of cell organelles called mitochondria in the brain reveals region- and cell-type-specific variability that tracks with ...